✦ LIBER ✦
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent — A phase II study of the EORTC early clinical trials group
✍ Scribed by Bruntsch, Uta; Dodion, Pierre; Ten Bokkel Huinink, Wim W.; Hansen, Heine H.; Pinedo, Herbert M.; Hansen, Mogens; Renard, Josette; Van Glabbeke, Martine
- Book ID
- 122727368
- Publisher
- Elsevier Science
- Year
- 1986
- Weight
- 325 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.